1
TABLE 2. Data of H NMR Spectra of Compounds 2-10, 12-14
Com-
pound
1Н NMR spectrum, δ, ppm, J (Hz)*
2
2
а
3.91 (2H, d, J = 7, SCH
2
); 5.04 (1H, d, J = 7, =CH
2
-cis); 5.21 (1H, d, J = 7, =CH -trans);
2
7
.71 (2H, d, J = 6, 3-, 5-H); 8.64 (2H, d, J = 6, 2-, 6-H)
b
4.51 (2H, s, SCH
2
); 7.27 (5H, m, Ph); 7.71 (2H, d, J = 6, 3-, 5-H);
8
.64 (2H, d, J = 6, 2-, 6-H)
2
2
3
4
c
4.13 (4H, s, SCH
4.01 (2H, s, SCH
5.22 (2H, s, NCH
2
); 7.69 (2H, d, J = 6, 3-, 5-H); 8.63 (2H, d, J = 6, 2-, 6-H)
); 7.68 (2H, d, J = 6, 3-, 5-H); 8.63 (2H, d, J = 6, 2-, 6-H)
d
2
2
); 7.57 (2H, d, J = 6, 3-, 5-H); 8.58 (2H, d, J = 6, 2-, 6-H)
а
1.36 (6H, m, CH
2
CH CH ); 2.62 (4H, m, CH NCH ); 4.84 (2H, s, NCH N);
2
2
2
2
2
7
.57 (2H, d, J = 6, 3-, 5-H); 8.56 (2H, d, J = 6, 2-, 6-H)
4
b
2.62 (4H, m, CH
2
OCH
2
); 3.42 (4H, m, CH
2
NCH
2
); 4.89 (2H, s, NCH N);
2
7
.60 (2H, d, J = 6, 3-, 5-H); 8.57 (2H, d, J = 6, 2-, 6-H)
5
6
7.38 (5H, m, Ph); 7.79 (2H, d, J = 6, 3-, 5-H); 8.79 (2H, d, J = 6, 2-, 6-H)
3.02 (2H, t, J = 7, CH ); 4.24 (2H, t, J = 7, NCH ); 7.07 (2H, d, J = 6, 3'-, 5'-H);
.58 (2H, d, J = 6, 3-, 5-H); 8.27 (2H, d, J = 6, 3'-, 5'-H); 8.62 (2H, d, J = 6, 2-, 6-H)
7.53 (2H, d, J = 6, 3-, 5-H); 8.53 (2H, d, J = 6, 2-, 6-H)
2
2
7
7
8
a
b
c
0.98 (3H, t, J = 7, CH
3
); 3.24 (2H, m, CH
); 8.53 (2H, d, J = 6, 2-, 6-H);
.11 and 10.33 (1H, s and 1H, s, C(О)NHNH)
); 7.25 (5H, m, Ph); 7.80 (2H, d, J = 6, 3-, 5-H);
.55 (1H, br. t, NH); 8.71 (2H, d, J = 6, 2-, 6-H);
.41 and 10.62 (1H, s and 1H, s, C(О)NHNH)
2
); 7.58 (2H, d, J = 6, 3-, 5-H);
7
9
.84 (1H, br. t, NHCH
2
8
8
4.76 (2H, d, J = 5, CH
2
8
9
2.16 (1H, t, J = 3, ≡CH); 4.19 (2H, d, J = 3, CH
C≡); 5.15 (2H, d, J = 6, CH
NH);
2
2
7
8
.60 (1H, s, NH); 7.93 (2H, d, J = 6, 3-, 5-H);
.80 (2H, d, J = 6, 2-, 6-H); 9.20 and 10.31 (1H, s and 1H, s, C(О)NHNH)
9
1
1
1.11 (3H, t, J = 7, CH
3
); 3.29 (2H, m, CH ); 7.49 (2H, d, J = 6, 3-, 5-H);
2
7
.49 (1H, s, NH); 8.42 (2H, d, J = 6, 2-, 6-H)
0
2
1.22 (3H, t, J = 7, CH
3
); 1.80 (3H, s, CH
3
CO); 4.11 (2H, q, J = 7, CH );
2
7
.60 (2H, d, J = 6, 3-, 5-H); 8.44 (2H, d, J = 6, 2-, 6-H)
0.98 (3H, t, J = 7, CH
3
); 3.17 (2H, m, CH
2
); 4.04 (2H, s, SCH );
2
7
9
.67 (2H, d, J = 6, 3-, 5-H); 8.55 (2H, d, J = 6, 2-, 6-H);
.04 (1H, s, NH); 9.51 (1H, s, NH); 9.95 (1H, s, NH)
); 1.97 (3H, s, CH C=); 3.43 (2H, s, CH
); 4.58 (2H, s, SCH ); 7.88 (2H, d, J = 6, 3-, 5-H);
.88 (2H, d, J = 6, 2-, 6-H); 10.64 (1H, s, NH)
); 4.15 (2H, m, CH CH
.95 (1H, s, =CH); 7.90 (2H, d, J = 6, 3-, 5-H); 8.83 (2H, d, J = 6, 2-, 6-H);
0.76 (1H, s, NH)
1
1
3
4
1.21 (3H, t, J = 7, CH
3
3
2
C=);
4
8
.17 (2H, m, CH
2
CH
3
2
1.28 (3H, t, J = 7, CH
3
2
3
); 4.55 (2H, s, SCH );
2
6
1
_
*
______
In DMSO-d
6
.
EXPERIMENTAL
1
The H NMR specra were measured on a Tesla BS 567 A (80 MHz) instrument, internal standard was
HMDS, solvent was DMSO-d . The IR spectra were recorded on a UR 10 spectrometer in KBr disks.
6
The initial 2-mercapto-5-(4-pyridyl)-1,3,4-oxadiazole (1) and [5-(4-pyridyl)-1,3,4-oxadiazol-2-ylthio]-
acetic acid (11) were obtained by the procedure of [2].
The physicochemical and spectral characteristics of the synthesized compounds are given in Tables 1
and 2.
2
-(2-Propenyl)thio-5-(4-pyridyl)-1,3,4-oxadiazole (2a). Oxadiazole 1 (2.69 g, 15 mmol) was added to
a solution of NaOH (0.6 g, 15 mmol) in water (30 ml), the solution obtained was filtered, TEBA (0.2 g) was
dissolved in it, and allyl bromide (1.82 g, 15 mmol) was added dropwise with stirring. The mixture was stirred
for 2 h at room temperature. The precipitated crystals of 2a were filtered off and washed with water.
8
56